First Eagle Investment Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-194,900
| Closed | -$478K | – | 171 |
|
|
2018
Q2 | $478K | Hold |
194,900
| – | – | ﹤0.01% | 158 |
|
|
2018
Q1 | $2.51M | Hold |
194,900
| – | – | 0.01% | 147 |
|
|
2017
Q4 | $2.16M | Buy |
194,900
+20,000
| +11% | +$222K | 0.01% | 190 |
|
|
2017
Q3 | $2.19M | Hold |
174,900
| – | – | ﹤0.01% | 197 |
|
|
2017
Q2 | $1.92M | Hold |
174,900
| – | – | ﹤0.01% | 199 |
|
|
2017
Q1 | $2.33M | Sell |
174,900
-100
| -0.1% | -$1.33K | 0.01% | 194 |
|
|
2016
Q4 | $1.5M | Hold |
175,000
| – | – | ﹤0.01% | 207 |
|
|
2016
Q3 | $1.61M | Hold |
175,000
| – | – | ﹤0.01% | 227 |
|
|
2016
Q2 | $1.38M | Hold |
175,000
| – | – | ﹤0.01% | 235 |
|
|
2016
Q1 | $1.23M | Hold |
175,000
| – | – | ﹤0.01% | 223 |
|
|
2015
Q4 | $2.01M | Hold |
175,000
| – | – | 0.01% | 199 |
|
|
2015
Q3 | $1.82M | Hold |
175,000
| – | – | ﹤0.01% | 200 |
|
|
2015
Q2 | $1.94M | Hold |
175,000
| – | – | ﹤0.01% | 202 |
|
|
2015
Q1 | $2.17M | Buy |
+175,000
| New | +$2.17M | 0.01% | 203 |
|